Literature DB >> 35588020

Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.

Şivge Kurgan1, Canan Önder2, Nur Balcı3, Nihan Akdoğan2, S Merve Altıngöz4, Muhittin A Serdar5, Meral Günhan2.   

Abstract

OBJECTIVES: Kynurenine pathway (KP) is the primary way of degrading tryptophan (TRP) and generates several bioactive metabolites (such as kynurenine (KYN), kynurenic acid (KYNA), 3-hydroxykynurenine (3OHKYN)) to regulate biological processes that include host-microbiome signaling and immune cell response. This study is aimed to determine the relationship between periodontal inflammation and tryptophan-kynurenine metabolism and identify their association with periodontal clinical parameters.
MATERIALS AND METHODS: Saliva and serum samples were collected from 20 stage III, grade B generalized periodontitis patients, and 20 periodontally healthy control individuals. Samples were analyzed for IL-6, KYN, TRP, KYN/TRP ratio, KYNA, 3OHKYN, picolinic acid (PA), and quinolinic acid (QA) by liquid chromatography-mass spectrometry. Clinical periodontal parameters (plaque index (PI), probing pocket depth (PPD), gingival recession (GR), clinical attachment loss (CAL), and bleeding on probing (BOP)) were recorded.
RESULTS: Clinical parameters were significantly higher in the periodontitis group (p < 0.001). Salivary IL-6, TRP, KYN, KYNA, PA, and QA levels were significantly higher and KYN/TRP ratio was significantly lower in periodontitis group than control group (p < 0.05). Serum KYN, KYN/TRP ratio and PA levels were significantly higher in periodontitis group than control group (p < 0.05). PPD, BOP, PI, and CAL had significantly positive correlations with salivary IL-6, TRP, PA, QA, and serum KYN and significantly negative correlations with salivary KYN/TRP ratio.
CONCLUSIONS: Our results suggest that periodontal inflammation plays a role in local and systemic tryptophan-kynurenine metabolism. CLINICAL RELEVANCE: Due to their effects on the immune and inflammatory systems, kynurenines may be potential agents for diagnosis and treatment of periodontal diseases.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Kynurenine pathway; Periodontitis; Tryptophan

Mesh:

Substances:

Year:  2022        PMID: 35588020     DOI: 10.1007/s00784-022-04528-4

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.606


  53 in total

1.  Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression.

Authors:  Leandro Z Agudelo; Teresa Femenía; Funda Orhan; Margareta Porsmyr-Palmertz; Michel Goiny; Vicente Martinez-Redondo; Jorge C Correia; Manizheh Izadi; Maria Bhat; Ina Schuppe-Koistinen; Amanda T Pettersson; Duarte M S Ferreira; Anna Krook; Romain Barres; Juleen R Zierath; Sophie Erhardt; Maria Lindskog; Jorge L Ruas
Journal:  Cell       Date:  2014-09-25       Impact factor: 41.582

2.  Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis.

Authors:  Masakazu Fukunaga; Yasuko Yamamoto; Misaki Kawasoe; Yuko Arioka; Yuki Murakami; Masato Hoshi; Kuniaki Saito
Journal:  J Histochem Cytochem       Date:  2012-08-15       Impact factor: 2.479

Review 3.  The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field.

Authors:  K A Polyzos; D F J Ketelhuth
Journal:  Hamostaseologie       Date:  2015-01-19       Impact factor: 1.778

Review 4.  Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.

Authors:  R Schwarcz
Journal:  Adv Pharmacol       Date:  2016-03-11

Review 5.  Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review.

Authors:  A Adibfar; M Saleem; K L Lanctot; N Herrmann
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

Review 6.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

7.  The Coevolution of IDO1 and AhR in the Emergence of Regulatory T-Cells in Mammals.

Authors:  Ursula Grohmann; Paolo Puccetti
Journal:  Front Immunol       Date:  2015-02-12       Impact factor: 7.561

Review 8.  The kynurenine pathway: a finger in every pie.

Authors:  Jonathan Savitz
Journal:  Mol Psychiatry       Date:  2019-04-12       Impact factor: 15.992

9.  Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.

Authors:  Carlo Breda; Korrapati V Sathyasaikumar; Shama Sograte Idrissi; Francesca M Notarangelo; Jasper G Estranero; Gareth G L Moore; Edward W Green; Charalambos P Kyriacou; Robert Schwarcz; Flaviano Giorgini
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

Review 10.  Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.

Authors:  Michael D Lovelace; Bianca Varney; Gayathri Sundaram; Nunzio F Franco; Mei Li Ng; Saparna Pai; Chai K Lim; Gilles J Guillemin; Bruce J Brew
Journal:  Front Immunol       Date:  2016-08-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.